5bjt
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | '''Unreleased structure''' | ||
- | + | ==Crystal structure of human FcRn with a peptide inhibitor at multiple sites== | |
- | + | <StructureSection load='5bjt' size='340' side='right' caption='[[5bjt]], [[Resolution|resolution]] 3.20Å' scene=''> | |
- | + | == Structural highlights == | |
- | + | <table><tr><td colspan='2'>[[5bjt]] is a 15 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5BJT OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5BJT FirstGlance]. <br> | |
- | + | </td></tr><tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=ACE:ACETYL+GROUP'>ACE</scene>, <scene name='pdbligand=NH2:AMINO+GROUP'>NH2</scene></td></tr> | |
- | [[Category: | + | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[3m17|3m17]], [[3m1b|3m1b]]</td></tr> |
+ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5bjt FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5bjt OCA], [http://pdbe.org/5bjt PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5bjt RCSB], [http://www.ebi.ac.uk/pdbsum/5bjt PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5bjt ProSAT]</span></td></tr> | ||
+ | </table> | ||
+ | == Disease == | ||
+ | [[http://www.uniprot.org/uniprot/B2MG_HUMAN B2MG_HUMAN]] Defects in B2M are the cause of hypercatabolic hypoproteinemia (HYCATHYP) [MIM:[http://omim.org/entry/241600 241600]]. Affected individuals show marked reduction in serum concentrations of immunoglobulin and albumin, probably due to rapid degradation.<ref>PMID:16549777</ref> Note=Beta-2-microglobulin may adopt the fibrillar configuration of amyloid in certain pathologic states. The capacity to assemble into amyloid fibrils is concentration dependent. Persistently high beta(2)-microglobulin serum levels lead to amyloidosis in patients on long-term hemodialysis.<ref>PMID:3532124</ref> <ref>PMID:1336137</ref> <ref>PMID:7554280</ref> <ref>PMID:4586824</ref> <ref>PMID:8084451</ref> <ref>PMID:12119416</ref> <ref>PMID:12796775</ref> <ref>PMID:16901902</ref> <ref>PMID:16491088</ref> <ref>PMID:17646174</ref> <ref>PMID:18835253</ref> <ref>PMID:18395224</ref> <ref>PMID:19284997</ref> | ||
+ | == Function == | ||
+ | [[http://www.uniprot.org/uniprot/FCGRN_HUMAN FCGRN_HUMAN]] Binds to the Fc region of monomeric immunoglobulins gamma. Mediates the uptake of IgG from milk. Possible role in transfer of immunoglobulin G from mother to fetus. [[http://www.uniprot.org/uniprot/B2MG_HUMAN B2MG_HUMAN]] Component of the class I major histocompatibility complex (MHC). Involved in the presentation of peptide antigens to the immune system. | ||
+ | == References == | ||
+ | <references/> | ||
+ | __TOC__ | ||
+ | </StructureSection> | ||
+ | [[Category: Badger, J]] | ||
+ | [[Category: Nienaber, V]] | ||
+ | [[Category: Amyloid]] | ||
+ | [[Category: Amyloidosis]] | ||
+ | [[Category: Cell membrane]] | ||
+ | [[Category: Disease mutation]] | ||
+ | [[Category: Disulfide bond]] | ||
+ | [[Category: Glycation]] | ||
+ | [[Category: Glycoprotein]] | ||
+ | [[Category: Igg-binding protein]] | ||
+ | [[Category: Immune response]] | ||
+ | [[Category: Immune system-inhibitor complex]] | ||
+ | [[Category: Immunoglobulin binding protein]] | ||
+ | [[Category: Immunoglobulin domain]] | ||
+ | [[Category: Mhc i]] | ||
+ | [[Category: Pyrrolidone carboxylic acid]] | ||
+ | [[Category: Receptor]] | ||
+ | [[Category: Secreted]] | ||
+ | [[Category: Transmembrane]] |
Revision as of 16:19, 22 March 2017
Crystal structure of human FcRn with a peptide inhibitor at multiple sites
|
Categories: Badger, J | Nienaber, V | Amyloid | Amyloidosis | Cell membrane | Disease mutation | Disulfide bond | Glycation | Glycoprotein | Igg-binding protein | Immune response | Immune system-inhibitor complex | Immunoglobulin binding protein | Immunoglobulin domain | Mhc i | Pyrrolidone carboxylic acid | Receptor | Secreted | Transmembrane